Maccura Biotechnology Co Ltd (300463) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.023x

Based on the latest financial reports, Maccura Biotechnology Co Ltd (300463) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥148.82 Million ≈ $21.78 Million USD) by net assets (CN¥6.38 Billion ≈ $933.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Maccura Biotechnology Co Ltd (300463) net asset quality to measure how much of total assets are equity-financed.

Maccura Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Maccura Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Maccura Biotechnology Co Ltd (300463) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Maccura Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Maccura Biotechnology Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shanghai Research Institute of Building Sciences Group Co. Ltd A
SHG:603153
N/A
Garware Technical Fibres Limited
NSE:GARFIBRES
0.005x
BMC Medical Co. Ltd. A
SHE:301367
N/A
LX International Corp
KO:001120
0.074x
PROSEGUR CASH UNSP.ADR/5
F:PQD0
N/A
Rayhoo Motor Dies Co Ltd
SHE:002997
0.032x
Shenzhen Sunshine Laser & Electronics Technology Co Ltd
SHE:300227
-0.059x
B-Soft Co Ltd
SHE:300451
-0.007x

Annual Cash Flow Conversion Efficiency for Maccura Biotechnology Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Maccura Biotechnology Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Maccura Biotechnology Co Ltd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥6.31 Billion
≈ $922.72 Million
CN¥602.33 Million
≈ $88.14 Million
0.096x -3.19%
2024-12-31 CN¥6.42 Billion
≈ $939.98 Million
CN¥633.80 Million
≈ $92.74 Million
0.099x -28.48%
2023-12-31 CN¥6.61 Billion
≈ $967.46 Million
CN¥912.09 Million
≈ $133.47 Million
0.138x +6.83%
2022-12-31 CN¥6.53 Billion
≈ $955.50 Million
CN¥843.22 Million
≈ $123.39 Million
0.129x -63.72%
2021-12-31 CN¥4.54 Billion
≈ $664.60 Million
CN¥1.62 Billion
≈ $236.57 Million
0.356x +30.32%
2020-12-31 CN¥4.01 Billion
≈ $586.12 Million
CN¥1.09 Billion
≈ $160.09 Million
0.273x +97.80%
2019-12-31 CN¥3.33 Billion
≈ $486.94 Million
CN¥459.52 Million
≈ $67.24 Million
0.138x +104.03%
2018-12-31 CN¥2.86 Billion
≈ $419.24 Million
CN¥193.91 Million
≈ $28.37 Million
0.068x +123.77%
2017-12-31 CN¥2.61 Billion
≈ $382.37 Million
CN¥79.03 Million
≈ $11.57 Million
0.030x +40.04%
2016-12-31 CN¥2.28 Billion
≈ $334.12 Million
CN¥49.32 Million
≈ $7.22 Million
0.022x +30.20%
2015-12-31 CN¥2.00 Billion
≈ $292.73 Million
CN¥33.18 Million
≈ $4.86 Million
0.017x -88.58%
2014-12-31 CN¥792.05 Million
≈ $115.90 Million
CN¥115.09 Million
≈ $16.84 Million
0.145x -10.73%
2013-12-31 CN¥604.48 Million
≈ $88.46 Million
CN¥98.39 Million
≈ $14.40 Million
0.163x -35.02%
2012-12-31 CN¥442.98 Million
≈ $64.82 Million
CN¥110.96 Million
≈ $16.24 Million
0.250x -8.71%
2011-12-31 CN¥311.77 Million
≈ $45.62 Million
CN¥85.55 Million
≈ $12.52 Million
0.274x --

About Maccura Biotechnology Co Ltd

SHE:300463 China Diagnostics & Research
Market Cap
$816.69 Million
CN¥5.58 Billion CNY
Market Cap Rank
#9702 Global
#2457 in China
Share Price
CN¥9.23
Change (1 day)
+1.54%
52-Week Range
CN¥8.11 - CN¥14.20
All Time High
CN¥59.01
About

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such a… Read more